Clinical Trial Update: Safety and Efficacy Study of PA9159 Nasal Spray for the Treatment of Seasonal Allergic Rhinitis [Phase 2]

View source ↗

Summary

Phase 2 safety and efficacy study of PA9159 nasal spray for seasonal allergic rhinitis has been completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Allergic Rhinitis

Drugs mentioned

• PA9159 Nasal Spray

Snippet

Sponsor: Anhui Palo Alto Pharmaceuticals, Inc. | Conditions: Allergic Rhinitis | Phase 2 | Status: COMPLETED